JP7165289B1 - N-置換アミノ酸残基を含む環状化合物の製造方法 - Google Patents

N-置換アミノ酸残基を含む環状化合物の製造方法 Download PDF

Info

Publication number
JP7165289B1
JP7165289B1 JP2022547692A JP2022547692A JP7165289B1 JP 7165289 B1 JP7165289 B1 JP 7165289B1 JP 2022547692 A JP2022547692 A JP 2022547692A JP 2022547692 A JP2022547692 A JP 2022547692A JP 7165289 B1 JP7165289 B1 JP 7165289B1
Authority
JP
Japan
Prior art keywords
compound
amino acid
solvate
crystal
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022547692A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022234864A1 (cg-RX-API-DMAC7.html
JPWO2022234864A5 (cg-RX-API-DMAC7.html
Inventor
増▲華▼ 侯
健太郎 瀬戸
耕太 田中
雅英 青木
彩 佐近
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP2022169217A priority Critical patent/JP2022186851A/ja
Application granted granted Critical
Publication of JP7165289B1 publication Critical patent/JP7165289B1/ja
Publication of JPWO2022234864A1 publication Critical patent/JPWO2022234864A1/ja
Publication of JPWO2022234864A5 publication Critical patent/JPWO2022234864A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2022547692A 2021-05-07 2022-05-06 N-置換アミノ酸残基を含む環状化合物の製造方法 Active JP7165289B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022169217A JP2022186851A (ja) 2021-05-07 2022-10-21 N-置換アミノ酸残基を含む環状化合物の製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2021079014 2021-05-07
JP2021079014 2021-05-07
JP2021188473 2021-11-19
JP2021188473 2021-11-19
PCT/JP2022/019606 WO2022234864A1 (ja) 2021-05-07 2022-05-06 N-置換アミノ酸残基を含む環状化合物の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022169217A Division JP2022186851A (ja) 2021-05-07 2022-10-21 N-置換アミノ酸残基を含む環状化合物の製造方法

Publications (3)

Publication Number Publication Date
JP7165289B1 true JP7165289B1 (ja) 2022-11-02
JPWO2022234864A1 JPWO2022234864A1 (cg-RX-API-DMAC7.html) 2022-11-10
JPWO2022234864A5 JPWO2022234864A5 (cg-RX-API-DMAC7.html) 2023-04-05

Family

ID=82156429

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022547692A Active JP7165289B1 (ja) 2021-05-07 2022-05-06 N-置換アミノ酸残基を含む環状化合物の製造方法
JP2022169217A Pending JP2022186851A (ja) 2021-05-07 2022-10-21 N-置換アミノ酸残基を含む環状化合物の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022169217A Pending JP2022186851A (ja) 2021-05-07 2022-10-21 N-置換アミノ酸残基を含む環状化合物の製造方法

Country Status (11)

Country Link
US (2) US12312379B2 (cg-RX-API-DMAC7.html)
EP (1) EP4086272A1 (cg-RX-API-DMAC7.html)
JP (2) JP7165289B1 (cg-RX-API-DMAC7.html)
KR (2) KR102569348B1 (cg-RX-API-DMAC7.html)
AR (1) AR125800A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022269959A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219081A1 (cg-RX-API-DMAC7.html)
IL (1) IL307918A (cg-RX-API-DMAC7.html)
MX (1) MX2023013098A (cg-RX-API-DMAC7.html)
TW (1) TW202309065A (cg-RX-API-DMAC7.html)
WO (1) WO2022234864A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI852183B (zh) 2011-12-28 2024-08-11 日商中外製藥股份有限公司 胜肽化合物之環化方法
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
US12312297B2 (en) 2018-11-07 2025-05-27 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
KR102994657B1 (ko) 2019-03-15 2026-07-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
WO2021090856A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 立体障害の大きなアミノ酸を含むペプチド化合物の製造方法
EP4043478A4 (en) 2019-11-07 2024-01-03 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION
KR20230169093A (ko) * 2021-05-07 2023-12-15 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물을 포함하는 제제 및 그의 제조 방법
IL316253A (en) 2022-05-06 2025-01-01 Chugai Pharmaceutical Co Ltd A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS
TW202428307A (zh) 2022-10-12 2024-07-16 日商中外製藥股份有限公司 包含胜肽、界面活性劑及聚合物的組成物
US20260132169A1 (en) * 2022-10-20 2026-05-14 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic peptide crystals
JPWO2024096023A1 (cg-RX-API-DMAC7.html) 2022-11-01 2024-05-10
CN120418263A (zh) 2022-12-28 2025-08-01 中外制药株式会社 环肽的纯化方法和生产方法
CN120731215A (zh) 2023-03-20 2025-09-30 中外制药株式会社 用于产生环肽的共晶的方法
TW202506706A (zh) * 2023-04-20 2025-02-16 日商中外製藥股份有限公司 環狀胜肽化合物的製造方法
EP4685150A1 (en) 2023-04-28 2026-01-28 Chugai Seiyaku Kabushiki Kaisha Method for producing amide group-containing compound using n-carboxyamino acid anhydride
CN121532404A (zh) 2023-09-28 2026-02-13 中外制药株式会社 用于使用混合酸酐程序生产肽化合物的方法
EP4759820A1 (en) 2023-12-27 2026-06-17 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide compound using stand-alone-type condensing agent
TW202535902A (zh) 2023-12-27 2025-09-16 日商中外製藥股份有限公司 使用2種以上的添加劑的胜肽化合物的製造方法
WO2025192626A1 (ja) 2024-03-13 2025-09-18 中外製薬株式会社 環構造を有するペプチド化合物の製造方法
WO2026009924A1 (ja) * 2024-07-03 2026-01-08 中外製薬株式会社 ペプチド化合物に含まれるオリゴマーの分析方法
WO2026121297A1 (ja) * 2024-12-04 2026-06-11 ペプチドリーム株式会社 ペプチド及びペイロードを含むコンジュゲート

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013100132A1 (ja) * 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 N-置換アミノ酸を含むペプチドの合成方法
WO2019117274A1 (ja) * 2017-12-15 2019-06-20 中外製薬株式会社 ペプチドの製造方法、及び塩基の処理方法
WO2020111238A1 (ja) * 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010063C2 (nl) 1998-09-10 2000-03-13 Holland Sweetener Co Werkwijze voor de bereiding van neotaam.
JP2003500415A (ja) * 1999-05-26 2003-01-07 アボット・ラボラトリーズ イオン交換樹脂をスカベンジャーとして使用して単離処理を最も少なくしたペプチド合成方法
TWI247012B (en) * 2001-07-19 2006-01-11 Akzo Nobel Nv Process for rapid solution synthesis of peptides
DK2612845T3 (da) * 2010-08-30 2020-11-02 Ajinomoto Kk Aromatisk forbindelse som indeholder specifik forgrening
WO2012171982A1 (en) * 2011-06-16 2012-12-20 Lonza Ltd A process for extraction of peptides and its application in liquid phase peptide synthesis
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
WO2015179434A1 (en) 2014-05-20 2015-11-26 Ohio State Innovation Foundation Small molecule ras inhibitors
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US10017540B2 (en) 2015-03-11 2018-07-10 California Institute Of Technology Cyclic peptide binder against oncogenic K-Ras
JP6116782B1 (ja) 2015-08-28 2017-04-19 積水メディカル株式会社 ベンジル化合物
WO2017150732A1 (ja) 2016-03-03 2017-09-08 中外製薬株式会社 チオール基をアミノ基近傍に有するアミノ酸をn末端に持つ非環状ペプチド-核酸複合体、そのライブラリー、およびそれから誘導される環状ペプチド-核酸複合体ライブラリーの製造方法
EP3442991A4 (en) 2016-04-15 2019-11-20 RA Pharmaceuticals, Inc. RAS-BINDING PEPTIDES AND METHODS OF USE
JP6283774B1 (ja) 2016-06-20 2018-02-21 積水メディカル株式会社 新規ジフェニルメタン保護剤
ES2830974T3 (es) 2016-07-25 2021-06-07 Sekisui Medical Co Ltd Nuevo agente protector de xanteno
TW201833127A (zh) 2017-02-27 2018-09-16 日商積水醫療股份有限公司 新穎四環式保護劑
EP3636807A4 (en) 2017-06-09 2021-07-28 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND WITH HIGH MEMBRANE PERMEABILITY AND LIBRARY WITH IT
KR20200100048A (ko) 2017-12-19 2020-08-25 세키스이 메디칼 가부시키가이샤 신규 알킬디페닐메탄 보호제
GB201805088D0 (en) * 2018-03-28 2018-05-09 Univ Warwick Macrocyclization of peptidomimetics
US12312297B2 (en) 2018-11-07 2025-05-27 Chugai Seiyaku Kabushiki Kaisha O-substituted serine derivative production method
JP7377679B2 (ja) 2018-11-19 2023-11-10 アムジエン・インコーポレーテツド がん治療のためのkrasg12c阻害剤及び1種以上の薬学的に活性な追加の薬剤を含む併用療法
WO2020122182A1 (ja) 2018-12-12 2020-06-18 中外製薬株式会社 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法
KR102994657B1 (ko) 2019-03-15 2026-07-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
EP4017454A4 (en) 2019-08-19 2023-09-20 Savvybaby Pty Ltd. BABY BOTTLE AND ASSOCIATED VALVE SYSTEM
WO2021090856A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 立体障害の大きなアミノ酸を含むペプチド化合物の製造方法
EP4043478A4 (en) 2019-11-07 2024-01-03 Chugai Seiyaku Kabushiki Kaisha CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION
JP7709920B2 (ja) 2019-12-27 2025-07-17 中外製薬株式会社 ペプチド化合物の合成法
WO2021246471A1 (ja) 2020-06-03 2021-12-09 中外製薬株式会社 高難度配列の効率的ペプチド縮合法
CN116507763A (zh) 2020-11-05 2023-07-28 中外制药株式会社 抑制由二酮哌嗪形成导致的缺损的肽合成方法
WO2022138891A1 (ja) 2020-12-25 2022-06-30 中外製薬株式会社 N-置換-アミノ酸残基を含むペプチド化合物の製造方法
EP4249496A4 (en) 2020-12-28 2024-11-13 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SUPPORTING AMINO ACIDS ON RESIN FOR SOLID PHASE SYNTHESIS
WO2022234639A1 (ja) 2021-05-07 2022-11-10 中外製薬株式会社 変異型ras(g12d)に対する選択的結合性を示す結合分子
AR125796A1 (es) 2021-05-07 2023-08-16 Chugai Pharmaceutical Co Ltd Compuesto cíclico que tiene una acción inhibitoria selectiva en kras sobre hras y nras
BR112023022875A2 (pt) 2021-05-07 2024-01-23 Chugai Pharmaceutical Co Ltd Uso farmacêutico de composto peptídico cíclico
KR20230169093A (ko) 2021-05-07 2023-12-15 추가이 세이야쿠 가부시키가이샤 환상 펩타이드 화합물을 포함하는 제제 및 그의 제조 방법
EP4206322A3 (en) 2021-12-28 2023-09-06 Chugai Seiyaku Kabushiki Kaisha Polypeptide and method for producing amino acid using same
CA3237911A1 (en) 2021-12-28 2023-07-06 Chugai Seiyaku Kabushiki Kaisha Method for producing n-alkyl amino acid and peptide including n-alkyl amino acid
TW202339786A (zh) 2022-01-21 2023-10-16 日商中外製藥股份有限公司 癌症之治療或預防用醫藥
CA3244999A1 (en) 2022-03-31 2025-06-13 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumors
EP4488283A1 (en) 2022-04-08 2025-01-08 Chugai Seiyaku Kabushiki Kaisha Production method for peptide compound
US20250353875A1 (en) 2022-05-02 2025-11-20 Chugai Seiyaku Kabushiki Kaisha Peptide synthesis method for suppressing defect caused by diketopiperazine formation
IL316253A (en) 2022-05-06 2025-01-01 Chugai Pharmaceutical Co Ltd A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS
JPWO2023219156A1 (cg-RX-API-DMAC7.html) 2022-05-13 2023-11-16
WO2023219152A1 (ja) 2022-05-13 2023-11-16 中外製薬株式会社 リチウム塩の析出工程を含む、アミノ酸の塩若しくはペプチド化合物の塩又はこれらの溶媒和物の製造方法
JPWO2024080333A1 (cg-RX-API-DMAC7.html) 2022-10-13 2024-04-18

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013100132A1 (ja) * 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 N-置換アミノ酸を含むペプチドの合成方法
WO2019117274A1 (ja) * 2017-12-15 2019-06-20 中外製薬株式会社 ペプチドの製造方法、及び塩基の処理方法
WO2020111238A1 (ja) * 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法

Also Published As

Publication number Publication date
AU2022269959A1 (en) 2023-11-16
CA3219081A1 (en) 2022-11-10
US20220411462A1 (en) 2022-12-29
EP4086272A1 (en) 2022-11-09
TW202309065A (zh) 2023-03-01
KR20230003614A (ko) 2023-01-06
KR102569348B1 (ko) 2023-08-21
JPWO2022234864A1 (cg-RX-API-DMAC7.html) 2022-11-10
MX2023013098A (es) 2023-11-16
AR125800A1 (es) 2023-08-16
US20250257094A1 (en) 2025-08-14
WO2022234864A1 (ja) 2022-11-10
US12312379B2 (en) 2025-05-27
JP2022186851A (ja) 2022-12-15
IL307918A (en) 2023-12-01
KR20230169072A (ko) 2023-12-15

Similar Documents

Publication Publication Date Title
JP2022186851A (ja) N-置換アミノ酸残基を含む環状化合物の製造方法
US12331072B2 (en) Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound
JP7766028B2 (ja) 高難度配列の効率的ペプチド縮合法
CN114867734B (zh) 肽化合物的合成法
WO2024219480A1 (ja) 環状ペプチド化合物の製造方法
JP7430297B2 (ja) N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法
EP4269422A1 (en) Method for producing peptide compound containing n-substituted-amino acid residue
IL319512A (en) Method for producing a cyclic peptide compound containing N-amino acids
TWI780152B (zh) 環狀有機化合物的製造方法
CN117279928A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
EA049862B1 (ru) Способ получения циклического соединения, содержащего n-замещенный аминокислотный остаток
CA3268063A1 (en) Method for producing n-substituted amino acid residue-containing cyclic peptide compound
HK40096738A (en) Methods for producing cyclic compounds comprising n-substituted amino acid residues
HK40120616A (en) Method for producing n-substituted amino acid residue-containing cyclic peptide compound
HK40080071A (en) Efficient peptide condensation method for difficult sequences

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220808

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220808

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220914

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220927

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221021

R150 Certificate of patent or registration of utility model

Ref document number: 7165289

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150